Allogeneic HSCT in MDS Patients Based on Risk According to R-IPSS
NCT04801563
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
80
Enrollment
OTHER
Sponsor class
Conditions
MDS and Allogeneic Stem Cell Transplantation
Interventions
OTHER:
MDS and AlloHSCT
Sponsor
University Of Perugia